Validation of liquid chromatography assay for the quantitation of (Z)-3-[2, 4-dimethyl-5-(2-oxo-1, 2-dihydro-indol-3-ylidenemethyl)-1H-pyrrol-3-y1]propionic acid (SU006668) in human plasma and its application to a phase I clinical trial

スポンサーリンク

概要

• 論文の詳細を見る
• 2003-02-25

著者

• Workman Paul

  Cancer Research Uk Centre For Cancer Therapeutics

• Asad Yasmin

  Cancer Research Uk Centre For Cancer Therapeutics The Institute Of Cancer Research

• Raynaud Florence

  Cancer Research Uk Centre For Cancer Therapeutics

• CROPP Gillian

  Cancer Research UK Centre for Cancer Therapeutics

• ADAMS Alison

  Cancer Research UK Centre for Cancer Therapeutics

• JUDSON Ian

  Cancer Research UK Centre for Cancer Therapeutics

• Asad Yasmin

  Cancer Research Uk Centre For Cancer Therapeutics

• O'donnell Anne

  Cancer Research Uk Centre For Cancer Therapeutics

関連論文

• A validated liquid chromatographic-tandem mass spectroscopy method for the quantification of abiraterone acetate and abiraterone in human plasma
• A liquid chromatographic-tandem mass spectrometric method for the determination of two selective thymidylate synthase inhibitors, BGC945 and BGC638, in mouse plasma
• Validation of liquid chromatography assay for the quantitation of (Z)-3-[2, 4-dimethyl-5-(2-oxo-1, 2-dihydro-indol-3-ylidenemethyl)-1H-pyrrol-3-y1]propionic acid (SU006668) in human plasma and its application to a phase I clinical trial

スポンサーリンク